In the autumn, under the guidance of the Department of Pharmaceutical Administration of the National Health Commission and the Shanghai Municipal Health Commission, the 6th Shanghai Seminar on Pharmaceutical Administration was successfully held under the guidance of the Department of Pharmaceutical Administration of the National Health Commission and the Shanghai Municipal Health Commission, jointly sponsored by the Shanghai Medical Association, the Shanghai Pharmaceutical Association, the Shanghai Hospital Association, and the Shanghai Medical and Health Development Foundation, and co-hosted by the China Pharmaceutical Industry Information Center and the Shanghai Clinical Pharmaceutical Administration Quality Control Center. This seminar is conducted in both directions in a combination of online and offline. Relevant leaders of the national and provincial and municipal health commissions and experts of industry associations conducted in-depth discussions on topics such as pharmaceutical management.
Leadership Speech
Drug use monitoring and clinical comprehensive evaluation are the basic work to promote the return of drugs to clinical value, an important measure to consolidate and improve the basic drug system, and a specific requirement for improving the drug supply guarantee system. It is hoped that through this seminar, the participants can brainstorm, pool their wisdom and jointly discuss, continuously strengthen China's pharmaceutical management capabilities, and make pharmaceutical work an important part of protecting people's health.
—Yi Chengdong, Deputy Director of Shanghai Municipal Health Commission
In recent years, china's pharmaceutical management has been continuously strengthened, and the level of rational drug use has gradually improved. The basic drug system has become the main starting point for medical institutions to promote rational drug use and reduce burden. It is hoped that through this seminar, we can further strengthen the pharmaceutical management and pharmacy services of medical institutions, increase the reform of drug use, improve the management level of medical institutions, and better protect the health of the people.
—Wang Jianrong, Inspector of the National Health Commission
Han Huixue, director of the Drug Policy Division of the Department of Pharmaceutical Policy of the National Health Commission, made a speech on the implementation of the national essential drug system and key tasks. He said that the basic drug system should adhere to the people's health as the center, and strive to achieve safe and effective drugs, adequate supply, reasonable prices, scientific use, and effectively enhance the people's sense of gain.
— Drug Policy Division, Department of Pharmaceutical Policy, National Health Commission
Director Han Huixue
Main Report
He Jiangjiang, director and associate researcher of the Health Policy Research Department of Shanghai Health and Health Development Research Center, made a keynote report on "The Basis and Promotion Ideas of Shanghai Comprehensive Clinical Evaluation of Drugs". He pointed out that the comprehensive clinical evaluation of drugs needs to gather the decision-making environment in Shanghai and establish a regional transformation application. On the basis of comprehensive analysis and demonstration, through multi-dimensional comparison, the implementation of the guidelines, channels and policies are determined.
Zhong Mingkang, director of Shanghai Clinical Pharmaceutical Affairs Management Quality Control Center and director of the Department of Pharmacy of Huashan Hospital affiliated to Fudan University, shared the relevant experience and cases of Chinese medicine work in the new crown epidemic with the guests in the report on "Shanghai Clinical Pharmaceutical Work Practice and Ideas". At the same time, it is proposed that the current training mode of clinical pharmacists needs to be improved, and more attention needs to be paid to the construction of clinical capabilities, scientific research demonstration capabilities and communication capabilities.
AC loops
In the exchange and discussion session, the relevant leaders of the provincial and municipal health commissions and clinical pharmacy experts expressed their opinions and spoke freely on topics such as improving the ability of drug administration management services and strengthening the clinical management of drugs.
Conclusion of the meeting
In the summary session, Wang Haiyin, director of the Health Technology Evaluation and Research Department of the Shanghai Health and Health Development Research Center, said that in recent years, China's pharmaceutical management has been continuously strengthened, and the level of rational drug use has gradually improved. At the same time, we will actively promote the reform of centralized procurement and use of drugs, improve the drug price formation mechanism, and standardize the order of drug production and circulation. In the future, it is hoped that more in-depth integration and exchanges can be carried out with the pharmaceutical administration departments of various provinces and cities, further consolidate and improve the basic drug system, and accelerate the construction of the drug supply guarantee system.
The seminar was presided over by Wu Wenhui, Director of the Pharmaceutical Administration Department of shanghai Municipal Health Commission, Guo Cheng, Chairman of Pharmaceutical Affairs Management Professional Committee of Shanghai Hospital Association and Director of Pharmacy Department of Shanghai Sixth People's Hospital, Liu Gaolin, Chairman of Clinical Pharmacy Branch of Shanghai Medical Association and Leader of Clinical Pharmacy Discipline of Shanghai First People's Hospital, Gao Shen, Director of Pharmacy Department of Changhai Hospital Affiliated to Naval Military Medical University, Zhu Deqiu, Director of Pharmacy Department of Shanghai Tongji Hospital, and Guo Wen, Director of China Pharmaceutical Industry Information Center.
■ Special support from Shanghai Pharmaceutical Group